Press "Enter" to skip to content

Roche’s Tecentriq scores a first-in-class double win in new liver cancer patients – FiercePharma

admin 0
  1. Roche’s Tecentriq scores a first-in-class double win in new liver cancer patients  FiercePharma
  2. Roche pushes late-comer Tecentriq as new liver cancer option  Reuters
  3. Roche immunotherapy cocktail boosts survival in liver cancer  Nasdaq
  4. Roche eyes filings for Tecentriq/Avastin combo in liver cancer  pmlive.com
  5. View full coverage on Google News

“liver cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *